Previsión

No hay datos de analistas disponibles para esta empresa.

Noticias Ir al feed de noticias

OssDsign: revenue stagnates in Q2 2026, stock falls nearly 6%

OssDsign reported sequentially flat revenue of SEK 37.8m (approx. $4m) in Q2 2026, a decline of 18.7% year‑on‑year in SEK. Gross margin improved slightly to 92.1% and adjusted EBIT improved versus Q1, but investors reacted negatively and the stock fell 5.95% to $3.95, near the 52‑week low. Management cites a revenue plateau, is expanding the US sales team, and highlights product progress on MIS Catalyst, a hydrophilic strip version and a planned new indication for 2026. Seasonal headwinds are expected in Q3; the company expects gradual, non‑linear progress for the remainder of the year. » Más en de.investing.com
OssDsign records strong growth, shares fall sharply after earnings call

OssDsign reported organic growth of 35% in Q3 2025 and a gross margin of 95.6%, along with the best EBIT in the company’s history; revenues for the first nine months rose 54% to SEK 135 million. Despite the strong metrics, the stock fell 15.99% to $10.82 after the earnings call, partly due to missing EPS/revenue details and a $1.5 million revenue shift from Q2. Management plans to double the US sales team by 2026 and expects further product and market growth, but warned of non-linear growth and execution risks. » Más en de.investing.com
OssDsign AB reports strong Q2 growth and increases gross margin

OssDsign AB recorded organic growth of 73% year‑on‑year in the second quarter of 2025 and an improved gross margin of 96.8%, despite currency effects from a strong US dollar. The company raised CHF 160 million through a share issue, plans to expand its US sales team and aims for a 30% market share and over USD 400 million in revenue by 2028. Investor reaction was positive and the stock rose sharply in pre‑market trading. » Más en de.investing.com

Datos financieros de la empresa

En el último trimestre, OSSDSIGN AB Aktie tuvo unos ingresos de 3,41M€ y un beneficio neto de −1,03M€

(EUR)	jun 2026	YoY
Ingresos	+3,41M	18,36%
Beneficio bruto	+3,14M	22,30%
Beneficio neto	−1,03M	37,52%
EBITDA	−1,07M	72,15%

Datos fundamentales

Métrica	Valor
Capitalización bursátil	+38,57M€
Número de acciones	110,63M
Máximo/mínimo de 52 semanas	+1,48€ - +0,30€
Dividendos	No
Beta	0,65
Ratio P/E	−8,54
Ratio PEG	−5,07
Ratio P/B	+1,49
Ratio P/S	+2,61

Perfil de la empresa

OssDsign AB (publ) entwickelt, produziert und vertreibt Implantate und Materialtechnologien für die Knochenregeneration in Schweden, Deutschland, den Vereinigten Staaten, dem Vereinigten Königreich, dem übrigen Europa und international. Zu den Produkten des Unternehmens gehören OSSDSIGN Cranial, eine Implantatlösung und entsprechendes Zubehör für die Rekonstruktion von Schädeldefekten bei Kranioplastik-Patienten, und OSSDSIGN Facial zur Behandlung posttraumatischer Skelettdeformationen und angeborener Skelettdefekte. Darüber hinaus bietet das Unternehmen OSSDSIGN Cranioplug zur Fixierung von Knochendeckeln und zur Abdeckung von Bohrlöchern sowie OssDsign Catalyst, ein nanosynthetisches Knochenersatzmaterial, das die Bildung von gesundem Knochengewebe anregt. Das Unternehmen wurde 2011 gegründet und hat seinen Hauptsitz in Uppsala, Schweden.